PubRank

Elaine W Kay

Author PubWeight™ 37.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 2005 4.18
2 Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer. Breast Cancer Res 2008 2.01
3 Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. J Clin Oncol 2011 1.84
4 Clinical application of a systems model of apoptosis execution for the prediction of colorectal cancer therapy responses and personalisation of therapy. Gut 2011 1.65
5 Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancer. Clin Cancer Res 2010 1.14
6 CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity. Breast Cancer Res 2012 0.98
7 Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy. Cancer Res 2013 0.97
8 The DeltaNp63 proteins are key allies of BRCA1 in the prevention of basal-like breast cancer. Cancer Res 2011 0.96
9 COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy. Int J Radiat Oncol Biol Phys 2005 0.95
10 Enhanced detection of microsatellite instability and mismatch repair gene expression in cutaneous squamous cell carcinomas. Mol Diagn Ther 2006 0.95
11 The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas. Eur J Gastroenterol Hepatol 2004 0.94
12 HER-2 analysis in tissue microarrays of archival human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization. Appl Immunohistochem Mol Morphol 2003 0.93
13 GLUT-1 expression and response to chemoradiotherapy in rectal cancer. Int J Cancer 2009 0.91
14 Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research. Nat Rev Cancer 2010 0.91
15 Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer. BMC Cancer 2009 0.91
16 Ensemble based system for whole-slide prostate cancer probability mapping using color texture features. Comput Med Imaging Graph 2011 0.90
17 The development and validation of the Virtual Tissue Matrix, a software application that facilitates the review of tissue microarrays on line. BMC Bioinformatics 2006 0.89
18 Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer. J Pathol 2009 0.89
19 HER2 positivity in breast carcinoma: a comparison of chromogenic in situ hybridization with fluorescence in situ hybridization in tissue microarrays, with targeted evaluation of intratumoral heterogeneity by in situ hybridization. Appl Immunohistochem Mol Morphol 2005 0.89
20 Glenohumeral articular cartilage changes in rotator cuff disease. J Shoulder Elbow Surg 2003 0.86
21 Loss of Fhit expression as a potential marker of malignant progression in preinvasive squamous cervical cancer. Gynecol Oncol 2002 0.86
22 Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target? Prostate 2013 0.85
23 The role of secreted frizzled-related protein 2 expression in prostate cancer. Histopathology 2011 0.83
24 Long-term protective effects of hypothermia on reperfusion injury post-testicular torsion. Scand J Urol Nephrol 2003 0.83
25 Cyclooxygenase-2 expression in stromal tumors of the gastrointestinal tract. Hum Pathol 2003 0.82
26 Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalization. Clin Cancer Res 2008 0.81
27 The analysis of serum response factor expression in bone and soft tissue prostate cancer metastases. Prostate 2014 0.81
28 Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients. J Gastroenterol Hepatol 2013 0.80
29 Cyclooxygenase-2 expression in chronic hepatitis C and the effect of interferon alpha treatment. J Gastroenterol Hepatol 2007 0.80
30 Investigation of molecular alterations of AKT-3 in triple-negative breast cancer. Histopathology 2013 0.79
31 Sustained expression of steroid receptor coactivator SRC-2/TIF-2 is associated with better prognosis in malignant pleural mesothelioma. J Thorac Oncol 2012 0.79
32 Evaluation of Zinc-α-2-Glycoprotein and Proteasome Subunit β-Type 6 Expression in Prostate Cancer Using Tissue Microarray Technology. Appl Immunohistochem Mol Morphol 2010 0.78
33 Analyzing proteasomal subunit expression reveals Rpt4 as a prognostic marker in stage II colorectal cancer. Int J Cancer 2011 0.77
34 Analysis of APC allelic imbalance/loss of heterozygosity and APC protein expression in cutaneous squamous cell carcinomas. Cancer Genomics Proteomics 2011 0.77
35 The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot study. Ann Surg Oncol 2014 0.76
36 Prognostic relevance of Fas (APO-1/CD95) ligand in human colorectal cancer. Eur J Gastroenterol Hepatol 2003 0.76
37 Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative. Digestion 2016 0.76
38 Unrepresentative astrocytoma biopsy sampling is partly overcome by assessment of the MIB-1-labelled growth fraction. J Clin Pathol 2007 0.75
39 A simple antigen retrieval method for the optimal demonstration of cyclin-D1 overexpression in formalin-fixed paraffin-embedded cases of mantle cell lymphoma. Appl Immunohistochem Mol Morphol 2005 0.75
40 An immunohistochemical and fluorescence in situ hybridization-based comparison between the Oracle HER2 Bond Immunohistochemical System, Dako HercepTest, and Vysis PathVysion HER2 FISH using both commercially validated and modified ASCO/CAP and United Kingdom HER2 IHC scoring guidelines. Appl Immunohistochem Mol Morphol 2010 0.75
41 Laboratory pressure cooker safety management. Appl Immunohistochem Mol Morphol 2003 0.75
42 High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients. Melanoma Res 2015 0.75
43 Comparison of dual-colour chromogenic in-situ hybridization and fluorescence in-situ hybridization in the assessment of HER2 gene amplification in breast carcinoma. Histopathology 2011 0.75
44 Follow-up of a pair of renal transplant recipients from a donor with a malignant lymphoma. Nephrol Dial Transplant 2002 0.75
45 The influence of anti-TNF therapy on CD31 and VEGF expression in colonic mucosa of Crohn's disease patients in relation to mucosal healing. Folia Histochem Cytobiol 2016 0.75
46 GIST with a twist--upregulation of PDGF-B resulting in metachronous gastrointestinal stromal tumor and dermatofibrosarcoma protuberans. J Gastrointest Surg 2010 0.75
47 Exogenous and endogenous angiogenic stimuli do not augment splenic autotransplantation. Eur J Surg 2002 0.75